Effects of melatonin and its receptor antagonist on retinal pigment epithelial cells against hydrogen peroxide damage

Molecular Vision

Volumn 18, Issue , 2012, Pages 1640-1648

  Rosen, Richard B ^a   Hu, Dan Ning ^a,b   Chen, Min ^b   McCormick, Steven A ^a,b   Walsh, Joseph ^a   Roberts, Joan E ^c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b NEW YORK EYE AND EAR INFIRMARY   (United States)

^c FORDHAM UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; LUZINDOLE; MELATONIN;

ARTICLE; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATIVE STRESS; PIGMENT CELL; PRIORITY JOURNAL; RETINAL PIGMENT EPITHELIAL CELL;

ANTIOXIDANTS; APOPTOSIS; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; MALE; MELATONIN; MIDDLE AGED; OXIDATIVE STRESS; PRIMARY CELL CULTURE; RECEPTORS, MELATONIN; RETINAL PIGMENT EPITHELIUM; TETRAZOLIUM SALTS; THIAZOLES; TRYPTAMINES;

EID: 84863336535     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J, Vision Health Cost-Effectiveness Study Group. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol 2009; 127:533-40. [PMID: 19365036]
2. Hogg R, Chakravarthy U. AMD and micronutrient antioxidants. Curr Eye Res 2004; 29:387-401. [PMID: 15764083]
3. Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Mol Vis 1999; 5:32. [PMID: 10562656]
4. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP. Oxidative Damage and protection of the RPE. Prog Retin Eye Res 2000; 19:205-21. [PMID: 10674708]
5. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004; 122:598-614. [PMID: 15078679]
6. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45:115-34. [PMID: 11033038]
7. van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC, Hofman A, de Jong PT. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 2005; 294:3101. [PMID: 16380590]
8. Rosen R, Hu DN, Perez V, Tai K, Yu GP, Chen M, Tone P, McCormick SA, Walsh J. Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients. Mol Vis 2009; 15:1673-9. [PMID: 19710945]
9. Baba K, Pozdeyev N, Mazzoni F, Contreras-Alcantara S, Liu C, Kasamatsu M. Martinez-Merlos T, Strettoi E, Iuvone PM, Tosini G. Melatonin modulates visual function and cell viability in the mouse retina via the MT1 melatonin receptor. Proc Natl Acad Sci USA 2009; 106:15043-8. [PMID: 19706469]
10. Radogna F, Paternoster L, Albertini MC, Cerella C, Accorsi A, Bucchini A, Spadoni G, Diamantini G, Tarzia G, De Nicola M, D'Alessio M, Ghibelli L. Melatonin antagonizes apoptosis via receptor interaction in U937 monocytic cells. J Pineal Res 2007; 43:154-62. [PMID: 17645693]
11. Juknat AA, Méndez Mdel V, Quaglino A, Fameli CI, Mena M, Kotler ML. Melatonin prevents hydrogen peroxide-induced Bax expression in cultured rat astrocytes. J Pineal Res 2005; 38:84-92. [PMID: 15683462]
12. Baldwin WS, Barrett JC. Melatonin attenuates hydrogen peroxide toxicity in MCF7 cells only at pharmacological concentrations. Biochem Biophys Res Commun 1998; 250:602-5. [PMID: 9784392]
13. Lezoualc'h F, Sparapani M, Behl C. N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB. J Pineal Res 1998; 24:168-78. [PMID: 9551854]
14. Yoo YM, Jeung EB. Melatonin-induced calbindin-D9k expression reduces hydrogen peroxide-mediated cell death in rat pituitary GH3 cells. J Pineal Res 2010; 48:83-93. [PMID: 20041988]
15. Yoo YM, Jeung EB. Melatonin-induced estrogen receptor alpha-mediated calbindin-D9k expression plays a role in H2O2-mediated cell death in rat pituitary GH3 cells. J Pineal Res 2009; 47:301-7. [PMID: 19796047]
16. Martín V, Sainz RM, Antolín I, Mayo JC, Herrera F, Rodríguez C. Several antioxidant pathways are involved in astrocyte protection by melatonin. J Pineal Res 2002; 33:204-12. [PMID: 12390502]
17. Chetsawang B, Putthaprasart C, Phansuwan-Pujito P, Govitrapong P. Melatonin protects against hydrogen peroxide-induced cell death signaling in SH-SY5Y cultured cells: involvement of nuclear factor kappa B, Bax and Bcl-2. J Pineal Res 2006; 41:116-23. [PMID: 16879316]
18. Das A, Belagodu A, Reiter RJ, Ray SK, Banik NL. Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress. J Pineal Res 2008; 45:117-24. [PMID: 18373557]
19. Espino J, Ortiz A, Bejarano I, Lozano GM, Monllor F, García JF, Rodríguez AB, Pariente JA. Melatonin protects human spermatozoa from apoptosis via melatonin receptor-and extracellular signal-regulated kinase-mediated pathways. Fertil Steril 2011; 95:2290-6. [PMID: 21497337]
20. Kimball SR, Abbas A, Jefferson LS. Melatonin represses oxidative stress-induced activation of the MAP kinase and mTOR signaling pathways in H4IIE hepatoma cells through inhibition of Ras. J Pineal Res 2008; 44:379-86. [PMID: 18410586]
21. Das A, McDowell M, Pava MJ, Smith JA, Reiter RJ, Woodward JJ, Varma AK, Ray SK, Banik NL. The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors. J Pineal Res 2010; 48:157-69. [PMID: 20082663]
22. Liang FQ, Green L, Wang C, Alssadi R, Godley BF. Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress. Exp Eye Res 2004; 78:1069-75. [PMID: 15109913]
23. Hu DN, Savage HE, Roberts JE. Uveal melanocytes, ocular pigment epithelium and Mueller cells in culture: in vitro toxicology. Int J Toxicol 2002; 21:465-72. [PMID: 12537643]
24. Wu WC, Hu DN, Gao HX, Chen M, Wang D, Rosen R, McCormick SA. Subtoxic levels hydrogen peroxide-induced production of interleukin-6 by retinal pigment epithelial cells. Mol Vis 2010; 16:1864-73. [PMID: 21031020]
25. Hu DN, McCormick SA, Ritch R, Pelton-Henrion K. Studies of human uveal melanocytes in vitro: Isolation, purification and cultivation of human uveal melanocytes. Invest Ophthalmol Vis Sci 1993; 34:2210-9. [PMID: 8505203]
26. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34:1-10. [PMID: 12485365]
27. Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B, Hardeland R. Melatonin: Nature's most versatile biological signal? FEBS J 2006; 273:2813-38. [PMID: 16817850]
28. Kovács J, Brodner W, Kirchlechner V, Arif T, Waldhauser F. Measurement of urinary melatonin: a useful tool for monitoring serum melatonin after its oral administration. J Clin Endocrinol Metab 2000; 85:666-70. [PMID: 10690873]
29. Boutin JA, Dietzel M. Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann N Y Acad Sci 1985; 453:205-14.
30. Boutin JA, Audinot V, Ferry G, Delagrange P. Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci 2005; 26:412-9. [PMID: 15992934].
31. Alarma-Estrany P, Pintor J. Melatonin receptors in the eye: location, second messengers and role in ocular physiology. Pharmacol Ther 2007; 113:507-22. [PMID: 17229466]
32. Rohrbach JM, Wollmann H, Heinze J, Gupta D, Thanos S. The role of melatonin in growth of malignant choroid melanoma. Ophthalmologe 1993; 90:289-93. [PMID: 8334334]
33. Roberts JE, Hu DN, Wishart JF. Pulse radiolysis studies of melatonin and chloromelatonin. J Photochem Photobiol B 1998; 42:125. [PMID: 9540219]
34. Roberts JE, Hu DN, Martinez L, Chignell CF. Photophysical studies on melatonin and its receptor agonists. J Pineal Res 2000; 29:94-9. [PMID: 10981822]
35. Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of oxidative stress. J Biomed Sci 2000; 7:444-58. [PMID: 11060493]
36. Boutin JA, Audinot V, Ferry G, Delagrange P. Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci 2005; 26:412-9. [PMID: 15992934]
37. Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Czarnocki Z. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 2003; 50:1129-46. [PMID: 14740000]
38. Reiter RJ, Tan DX, Manchester LC, Pilar Terron M, Flores LJ, Koppisepi S. Medical implications of melatonin: receptormediated and receptor-independent actions. Adv Med Sci 2007; 52:11-28. [PMID: 18217386]
39. Reiter RJ, Tan DX, Terron MP, Flores LJ, Czarnocki Z. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 2007; 54:1-9. [PMID: 17351668]
40. Martín M, Macías M, Escames G, León J, Acuña-Castroviejo D. Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J 2000; 14:1677. [PMID: 10973915]
41. Samiec PS, Drews-Botsch C, Flagg EW, Kurtz JC, Sternberg P Jr, Reed RL, Jones DP. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 1998; 24:699. [PMID: 9586798]
42. Tanaka D, Furusawa K, Kameyama K, Okamoto H, Doi M. Melatonin signaling regulates locomotion behavior and homeostatic states through distinct receptor pathways in Caenorhabditis elegans. Neuropharmacology 2007; 53:157-68. [PMID: 17573073]
43. Tam CW, Mo CW, Yao KM, Shiu SY. Signaling mechanisms of melatonin in antiproliferation of hormone-refractory 22Rv1 human prostate cancer cells: implications for prostate cancer chemoprevention. J Pineal Res 2007; 42:191-202. [PMID: 17286752]
44. Shiu SY, Pang B, Tam CW, Yao KM. Signal transduction of receptor-mediated antiproliferative action of melatonin on human prostate epithelial cells involves dual activation of Gα(s) and Gα(q) proteins. J Pineal Res 2010; 49:301-11. [PMID: 20695976]
45. Scott FF, Belle MD, Delagrange P, Piggins HD. Electrophysiological effects of melatonin on mouse Per1 and non-Per1 suprachiasmatic nuclei neurones in vitro. J Neuroendocrinol 2010; 22:1148-56. [PMID: 20819119]
46. Sotthibundhu A, Phansuwan-Pujito P, Govitrapong P. Melatonin increases proliferation of cultured neural stem cells obtained from adult mouse subventricular zone. J Pineal Res 2010; 49:291-300. [PMID: 20663047]
47. Romero A, Egea J, García AG, López MG. Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SHSY5Y neuroblastoma cells. J Pineal Res 2010; 49:141-8. [PMID: 20536682]
48. Cabrera J, Negrín G, Estévez F, Loro J, Reiter RJ, Quintana J. Melatonin decreases cell proliferation and induces melanogenesis in human melanoma SK-MEL-1 cells. J Pineal Res 2010; 49:45-54. [PMID: 20459460]
49. Zmijewski MA, Sweatman TW, Slominski AT. The melatoninproducing system is fully functional in retinal pigment epithelium (ARPE-19). Mol Cell Endocrinol 2009; 307:211-6. [PMID: 19409957]
50. Siu AW, Reiter RJ, To CH. The efficacy of vitamin E and melatonin as antioxidants against lipid peroxidation in rat retinal homogenates. J Pineal Res 1998; 24:239-44. [PMID: 9572534]
51. Marchiafava PL, Longoni B. Melatonin as an antioxidant in retinal photoreceptors. J Pineal Res 1999; 26:184-9. [PMID: 10231733]
52. Guajardo MH, Terrasa AM, Catalá A. Protective effect of indoleamines on in vitro ascorbate-Fe2+ dependent lipid peroxidation of rod outer segment membranes of bovine retina. J Pineal Res 2003; 35:276-82. [PMID: 14521634]
53. Guajardo MH, Terrasa AM, Catalá A. Lipid-protein modifications during ascorbate-Fe2+ peroxidation peroxidation of photoreceptor membranes: protective effect of melatonin. J Pineal Res 2006; 41:201-10. [PMID: 16948780]
54. Yi C, Pan X, Yan H, Guo M, Pierpaoli W. Effects of melatonin in age-related macular degeneration. Ann N Y Acad Sci 2005; 1057:384-92. [PMID: 16399908]
55. Arendt J, Van Someren EJ, Appleton R, Skene DJ, Akerstedt T. Clinical update: melatonin and sleep disorders. Clin Med 2008; 8:381-3. [PMID: 18724603]
56. Mills E, Wu P, Seely D, Guyatt G. Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J Pineal Res 2005; 39:360-6. [PMID: 16207291]
57. Gonzalez R, Sanchez A, Ferguson JA, Balmer C, Daniel C, Cohn A, Robinson WA. Melatonin therapy of advanced human malignant melanoma. Melanoma Res 1991; 1:237-43. [PMID: 1823632]
58. Waldhauser F, Waldhauser M, Lieberman HR, Deng MH, Lynch HJ, Wurtman RJ. Bioavailability of oral melatonin in humans. Neuroendocrinology 1984; 39:307-13. [PMID: 6493445]